The DOI matches its Crossref record; 60 of the 63 references it cites were found in a registry or an index.
Intestinal myofibroblasts in innate immune responses of the intestine
Open accessAbstract
Background & aims Intestinal myofibroblasts are known to respond to inflammatory signals and may play a role in Crohn's disease-associated fibrosis. However, putative involvement by myofibroblasts in innate immune responses as part of intestinal host defense has not been characterized. We therefore analyzed expression and regulation of toll-like receptors (TLRs) in colonic human myofibroblasts (CCD-18) and primary human colonic myofibroblasts in comparison with human lung myofibroblasts (CCD-37).Methods Expression of TLRs (1-10) and NOD 1 and 2 was assessed before and after stimulation with either lipopolysaccharide (LPS) or lipoteichoic acid (LTA) by using a custom microarray, reverse-transcription polymerase chain reaction, Northern blot and Western blot analysis, and immunohistochemistry. Activation of signaling pathways, translocation of p65, and secretion of interleukin (IL)-8 were determined.Results Messenger RNAs encoding for TLR1-9, as well as NOD1 and NOD2, were amplified from cultured and primary human intestinal myofibroblasts. After stimulation with LPS or LTA, a 1.5-4.2-fold up-regulation of TLRs (2, 3, 4, 6, 7) and elements of the signaling cascade (MyD88, TIR domain-containing adapter protein [TIRAP]) was observed. CCD-18 and CCD-37 cells expressed TLR 2 and 4 protein, which were located primarily on the cell membrane. Stimulation with LTA or LPS resulted in activation of the mitogen-activated protein kinases pathway, nuclear translocation of p65, and significantly increased IL-8 secretion.Conclusions Bacterial components directly activate intestinal myofibroblasts expressing TLRs. These cells may therefore participate in innate immune responses by sensing and responding to bacterial products that have penetrated into the subepithelial compartment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“‘Dysbiosis’, defined as an altered disease-associated microbiome, has been shown to increase with the severity of NASH in both rodents and in humans. This is paralleled and closely related to increased intestinal permeability, bacterial translocation into the portal system and activation of pro-inflammatory pathways.148”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [148]
In the citing paper
“The downstream kinase IRAK4 controlled pericyte myofibroblast conversion in vitro and pharmacological inhibition of MyD88 signaling with an IRAK4 inhibitor reduced fibrosis by attenuating tissue injury in vivo167”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [167]
In the citing paper
“In the kidney, pericytes, a myofibroblast precursor, activate a TLR2/TLR4/MyD88-dependent proinflammatory program in response to tissue injury167”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [167]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toll-like receptors and innate immunity
Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308
Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27489 · Cited by 3,396
Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase
Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Dyk, D. E. V., Pitts, W. J., Earl, R. A., Hobbs, F. W., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18623 · Cited by 3,016
A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
Han, J., Lee, J. D., Bibbs, L., & Ulevitch, R. J. (1994) · Science · doi:10.1126/science.7914033 · Cited by 2,647
Cyclooxygenase in biology and disease
Dubois, R. N., Abramson, S. B., Crofford, L., Gupta, R., Simon, L. S., Putte, L., & Lipsky, P. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,606
MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4
Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., & Kimoto, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1777 · Cited by 2,187
Ozinsky, A., Underhill, D. M., Fontenot, J. D., Hajjar, A. M., Smith, K. D., Wilson, C. B., Schroeder, L. A., & Aderem, A. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250476497 · Cited by 2,086
Cuenda, A., Rouse, J., Doza, Y. N., Meier, R., Cohen, P., Gallagher, T. F., Young, P. R., & Lee, J. C. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00357-f · Cited by 2,086
Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal Transduction
Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J., & Gusovsky, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10689 · Cited by 1,924
Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2
Schwandner, R., Dziarski, R., Wesche, H., Rothe, M., & Kirschning, C. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17406 · Cited by 1,704
Research works printed but not linked: 1
- Fiocchi, 1997, Intestinal inflammation, Am J Physiol, 273, G769
Cited by
Sorted by citations
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Fibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868
Targeting integrin pathways: mechanisms and advances in therapy
Pang, X., He, X., Qiu, Z., Zhang, H., Xie, R., Liu, Z., Gu, Y., Zhao, N., Xiang, Q., & Cui, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01259-6 · Cited by 1,275
Vaishnava, S., Behrendt, C. L., Ismail, A. S., Eckmann, L., & Hooper, L. V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808723105 · Cited by 1,019
Nod-like proteins in immunity, inflammation and disease
Fritz, J. H., Ferrero, R. L., Philpott, D. J., & Girardin, S. E. (2006) · Nature Immunology · doi:10.1038/ni1412 · Cited by 889
Host Responses in Tissue Repair and Fibrosis
Duffield, J. S., Lupher, M., Thannickal, V. J., & Wynn, T. A. (2012) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-163930 · Cited by 644
TLR Signaling in the Gut in Health and Disease
Abreu, M. T., Fukata, M., & Arditi, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4453 · Cited by 577
Crosstalk between fibroblasts and inflammatory cells
Linthout, S. V., Miteva, K., & Tschöpe, C. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu062 · Cited by 588
Crohn's disease complicated by strictures: a systematic review
Rieder, F., Zimmermann, E. M., Remzi, F. H., & Sandborn, W. J. (2013) · Gut · doi:10.1136/gutjnl-2012-304353 · Cited by 514
Leaphart, C. L., Cavallo, J. A., Gribar, S. C., Çetin, S., Li, J., Branca, M. F., Dubowski, T. D., Sodhi, C. P., & Hackam, D. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4808 · Cited by 484
Epithelial Toll-like receptors and their role in gut homeostasis and disease
Burgueño, J. F., & Abreu, M. T. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0261-4 · Cited by 419
Mesenchymal Cells of the Intestinal Lamina Propria
Powell, D. W., Pinchuk, I. V., Saada, J. I., Chen, X., & Mifflin, R. C. (2011) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100646 · Cited by 412
Cytokine mediated tissue fibrosis
Borthwick, L. A., Wynn, T. A., & Fisher, A. J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.014 · Cited by 375
BACTERIAL INTERACTIONS WITH CELLS OF THE INTESTINAL MUCOSA: TOLL-LIKE RECEPTORS AND NOD2
Cario, E. (2005) · Gut · doi:10.1136/gut.2004.062794 · Cited by 369
Intestinal fibrosis in IBD—a dynamic, multifactorial process
Rieder, F., & Fiocchi, C. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.31 · Cited by 347
Toll-like Receptors and Inflammatory Bowel Disease
Lu, Y., Li, X., Liu, S., Zhang, Y., & Zhang, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00072 · Cited by 355
Toll-like receptors in inflammatory bowel diseases: A decade later
Cario, E. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21282 · Cited by 357
The Yin and Yang of Toll-like receptors in cancer
Pradère, J., Dapito, D. H., & Schwabe, R. F. (2013) · Oncogene · doi:10.1038/onc.2013.302 · Cited by 344
Toll-like receptors in inflammation, infection and cancer
Chen, K., Huang, J., Gong, W., Iribarren, P., Dunlop, N. M., & Wang, J. M. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.05.016 · Cited by 329
Wound healing and fibrosis in intestinal disease
Rieder, F., Brenmoehl, J., Leeb, S. N., Schölmerich, J., & Rogler, G. (2006) · Gut · doi:10.1136/gut.2006.090456 · Cited by 307
Human gut microbiota: the links with dementia development
Alkasir, R., Li, J., Li, X., Jin, M., & Zhu, B. (2016) · Protein & Cell · doi:10.1007/s13238-016-0338-6 · Cited by 289
Cellular and molecular mechanisms of intestinal fibrosis
Speca, S. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i28.3635 · Cited by 277
Kim, Y., Kamada, N., Shaw, M. H., Warner, N. E., Chen, G., Franchi, L., & Núñez, G. (2011) · Immunity · doi:10.1016/j.immuni.2011.04.013 · Cited by 242
NOD2 mediates anti‐inflammatory signals induced by TLR2 ligands: implications for Crohn's disease
Netea, M. G., Kullberg, B. J., de Jong, D. J., Franke, B., Sprong, T., Naber, A. H. J., Drenth, J. P. H., & van der Meer, J. W. M. (2004) · European Journal of Immunology · doi:10.1002/eji.200425229 · Cited by 216
An Essential Mesenchymal Function for miR-143/145 in Intestinal Epithelial Regeneration
Chivukula, R. R., Shi, G., Acharya, A., Mills, E. W., Zeitels, L. R., Anandam, J., Abdelnaby, A. A., Balch, G. C., Mansour, J. C., Yopp, A. C., et al. (2014) · Cell · doi:10.1016/j.cell.2014.03.055 · Cited by 213
Fibroblasts and myofibroblasts of the intestinal lamina propria in physiology and disease
Roulis, M., & Flavell, R. A. (2016) · Differentiation · doi:10.1016/j.diff.2016.05.002 · Cited by 204
Mesenchymal Cells in Colon Cancer
Koliaraki, V., Pallangyo, C. K., Greten, F. R., & Kollias, G. A. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.11.049 · Cited by 200
Infectious disease, the innate immune response, and fibrosis
Meneghin, A., & Hogaboam, C. M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30595 · Cited by 200
Fibrosis in IBD: from pathogenesis to therapeutic targets
Rieder, F., Mukherjee, P. K., Massey, W. J., Wang, Y., & Fiocchi, C. (2024) · Gut · doi:10.1136/gutjnl-2023-329963 · Cited by 208
Machida, K., Cheng, K. T.-H., Sung, V. M.-H., Levine, A. M., Foung, S. K. H., & Lai, M. M. C. (2005) · Journal of Virology · doi:10.1128/jvi.80.2.866-874.2006 · Cited by 195
Identification and expression of Toll-like receptors 1–10 in selected bovine and ovine tissues
Menzies, M., & Ingham, A. B. (2005) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2005.06.014 · Cited by 173
Peptidoglycan Signaling in Innate Immunity and Inflammatory Disease
McDonald, C., Inohara, N., & Núñez, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.r500001200 · Cited by 169
Latella, G., Rogler, G., Bamias, G., Breynaert, C. M., Florholmen, J., Pellino, G., Reif, S. S., Speca, S., & Lawrance, I. C. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.03.008 · Cited by 169
Pathophysiology of Liver Fibrosis
Pinzani, M. (2015) · Digestive Diseases · doi:10.1159/000374096 · Cited by 164
Role of toll-like receptors in inflammatory bowel disease
Kordjazy, N., Haj‐Mirzaian, A., Haj‐Mirzaian, A., Rohani, M. M., Gelfand, E. W., Rezaei, N., & Abdolghaffari, A. H. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.11.017 · Cited by 161
TLR4 Promotes Fibrosis but Attenuates Tubular Damage in Progressive Renal Injury
Pulskens, W. P. C., Rampanelli, E., Teske, G. J. D., Butter, L. M., Claessen, N., Luirink, I. K., van der Poll, T., Florquin, S., & Leemans, J. C. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009070722 · Cited by 155
TGF-β1 gene transfer to the mouse colon leads to intestinal fibrosis
Vallance, B. A., Gunawan, M. I., Hewlett, B. R., Berčík, P., Kampen, C. V., Galeazzi, F., Sime, P. J., Gauldie, J., & Collins, S. M. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00051.2005 · Cited by 151
The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases
Jager, P. L. D., Franchimont, D. P., Waliszewska, A., Bitton, A., Cohen, A., Langelier, D., Bélaïche, J., Vermeire, S., Farwell, L. M., Goris, A., et al. (2007) · Genes and Immunity · doi:10.1038/sj.gene.6364398 · Cited by 145
Self-citationRegulation of wound healing and organ fibrosis by toll-like receptors
Huebener, P., & Schwabe, R. F. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.017 · Cited by 140
Mechanisms of Pediatric Inflammatory Bowel Disease
Peloquin, J. M., Goel, G., Villablanca, E. J., & Xavier, R. J. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112151 · Cited by 141
Fibrosis in Ulcerative Colitis
Gordon, I. O., Agrawal, N., Goldblum, J. R., Fiocchi, C., & Rieder, F. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000080 · Cited by 139
Moue, M., Tohno, M., Shimazu, T., Kido, T., Aso, H., Saito, T., & Kitazawa, H. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.11.006 · Cited by 134
Toll-like receptors, wound healing, and carcinogenesis
Kluwe, J., Mencin, A. M., & Schwabe, R. F. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0426-z · Cited by 137
The Nodosome: Nod1 and Nod2 control bacterial infections and inflammation
Tattoli, I., Travassos, L. H., Carneiro, L. A. M., Magalhaes, J. G., & Girardin, S. E. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0083-2 · Cited by 131
Functional consequences of NOD2 (CARD15) mutations
Abraham, C., & Cho, J. H. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000225332.83861.5f · Cited by 130
Role of intestinal subepithelial myofibroblasts in inflammation and regenerative response in the gut
Andoh, A., Bamba, S., Brittan, M., Fujiyama, Y., & Wright, N. A. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.12.004 · Cited by 131
Update on the pathophysiology of liver fibrosis
Pinzani, M., & Macías‐Barragán, J. (2010) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.10.47 · Cited by 126
Lü, P., Sodhi, C. P., & Hackam, D. J. (2013) · Pathophysiology · doi:10.1016/j.pathophys.2013.11.007 · Cited by 124
Intestinal stromal cells in mucosal immunity and homeostasis
Owens, B. M. J., & Simmons, A. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.125 · Cited by 117
The Role of Toll-Like Receptor 2 in Inflammation and Fibrosis during Progressive Renal Injury
Leemans, J. C., Butter, L. M., Pulskens, W. P. C., Teske, G. J. D., Claessen, N., van der Poll, T., & Florquin, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005704 · Cited by 118
Role of Toll-like receptors in health and diseases of gastrointestinal tract
Harris, G. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i14.2149 · Cited by 119
Novel mechanisms and clinical trial endpoints in intestinal fibrosis*
Wang, J., Lin, S., Brown, J. M., Wagoner, D. R. V., Fiocchi, C., & Rieder, F. (2021) · Immunological Reviews · doi:10.1111/imr.12974 · Cited by 121
Understanding the cellular interactome of non-alcoholic fatty liver disease
Wallace, S. J., Tacke, F., Schwabe, R. F., & Henderson, N. C. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100524 · Cited by 116
Layers of mutualism with commensal bacteria protect us from intestinal inflammation
Mueller, C., & Macpherson, A. J. (2006) · Gut · doi:10.1136/gut.2004.054098 · Cited by 109
Fibrostenotic strictures in Crohn’s disease
Yoo, J. H., Holubar, S. D., & Rieder, F. (2020) · Intestinal Research · doi:10.5217/ir.2019.09148 · Cited by 110
Pinchuk, I. V., Mifflin, R. C., Saada, J. I., & Powell, D. W. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-010-0135-y · Cited by 104
Inflammatory Bowel Disease Genetics: Nod2
Cho, J. H., & Abraham, C. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.58.061705.145024 · Cited by 105
Chen, S., Yuan, J., Yao, S., Jin, Y., Chen, G., Tian, W., Xi, J., Xu, Z., Weng, D., & Chen, J. (2015) · Autophagy · doi:10.1080/15548627.2015.1109765 · Cited by 103
Pathogenesis of fibrostenosing Crohn's disease
Li, J., Mao, R., Kurada, S. V., Wang, J., Lin, S., Chandra, J., & Rieder, F. (2019) · Translational research · doi:10.1016/j.trsl.2019.03.005 · Cited by 103
Inflammation-independent TL1A-mediated intestinal fibrosis is dependent on the gut microbiome
Jacob, N., Jacobs, J. P., Kumagai, K., Ha, C. W. Y., Kanazawa, Y., Lagishetty, V., Altmayer, K., Hamill, A. M., Von Arx, A., Sartor, R. B., et al. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0055-y · Cited by 102
Walton, K. L. W., Holt, L. C., & Sartor, R. B. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00022.2008 · Cited by 99
Flannigan, K. L., Nieves, K., Szczepanski, H. E., Serra, A., Lee, J. W., Alston, L. A., Ramay, H. R., Mani, S., & Hirota, S. A. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.10.014 · Cited by 98
Hofmann, C., Chen, N., Obermeier, F., Paul, G., Büchler, C., Kopp, A., Falk, W., & Schäffler, A. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21647 · Cited by 95
Host–bacterial interactions in inflammatory bowel disease
Mahida, Y. R., & Rolfe, V. E. (2004) · Clinical Science · doi:10.1042/cs20040136 · Cited by 92
Regulation of Fibrosis by the Immune System
Lupher, M., & Gallatin, W. M. (2006) · Advances in immunology · doi:10.1016/s0065-2776(05)89006-6 · Cited by 93
Up-Regulation of NOD1 and NOD2 through TLR4 and TNF-.ALPHA. in LPS-treated Murine Macrophages
Takahashi, Y., ISUZUGAWA, K., Murase, Y., Imai, M., Yamamoto, S., Iizuka, M., Akira, S., Bahr, G. M., Momotani, E., Hori, M., et al. (2006) · Journal of Veterinary Medical Science · doi:10.1292/jvms.68.471 · Cited by 87
Andoh, A., Bamba, S., Fujiyama, Y., Brittan, M., & Wright, N. A. (2005) · Journal of Gastroenterology · doi:10.1007/s00535-005-1727-4 · Cited by 88
Development of Fibrosis in Acute and Longstanding Ulcerative Colitis
de Bruyn, J. R., Meijer, S. L., Wildenberg, M. E., Bemelman, W. A., van den Brink, G. R., & D’Haens, G. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv133 · Cited by 89
Mueller, T., Beutler, C., Picó, A. H., Shibolet, O., Pratt, D. S., Pascher, A., Neuhaus, P., Wiedenmann, B. J., Berg, T., & Podolsky, D. K. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02635.x · Cited by 85
Self-citationFux, A. C., Casonato Melo, C., Michelini, S., Swartzwelter, B. J., Neusch, A., Italiani, P., & Himly, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098395 · Cited by 83
TLR4 Activation Enhances the PD-L1–Mediated Tolerogenic Capacity of Colonic CD90+ Stromal Cells
Beswick, E. J., Johnson, J. R., Saada, J. I., Humen, M. A., House, J., Dann, S. M., Qiu, S., Brasier, A. R., Powell, D. W., Reyes, V. E., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1203441 · Cited by 82
Noratto, G. D., Kim, Y., Talcott, S. T., & Mertens‐Talcott, S. U. (2011) · Fitoterapia · doi:10.1016/j.fitote.2011.01.013 · Cited by 82
Bettenworth, D., & Rieder, F. (2014) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-7-5 · Cited by 80
Osteopontin and Mucosal Protection
Sodek, J., Silva, A. P. B. D., & Zohar, R. (2006) · Journal of Dental Research · doi:10.1177/154405910608500503 · Cited by 81
Drobiova, H., Sindhu, S. T. A. K., Ahmad, R., Haddad, D., Al‐Mulla, F., & Madhoun, A. S. A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1211217 · Cited by 95
Gut microbiota: sculptors of the intestinal stem cell niche in health and inflammatory bowel disease
Markandey, M., Bajaj, A., Ilott, N. E., Kedia, S., Travis, S. P. L., Powrie, F. M., & Ahuja, V. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1990827 · Cited by 85
The Gut Microbiome in Intestinal Fibrosis: Environmental Protector or Provocateur?
Rieder, F. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004731 · Cited by 78
Vandoros, G. P., Konstantinopoulos, P. A., Sotiropoulou‐Bonikou, G., Kominea, A., Papachristou, G. I., Karamouzis, M. V., Gkermpesi, M., Varakis, I., & Papavassiliou, A. G. (2005) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-005-0042-z · Cited by 77
Innate immunity and mucosal bacterial interactions in the intestine
Eckmann, L. (2004) · Current Opinion in Gastroenterology · doi:10.1097/00001574-200403000-00006 · Cited by 71
The Role of the Microbiome in the Etiopathogenesis of Colon Cancer
Tekle, G. E., Andreeva, N., & Garrett, W. S. (2024) · Annual Review of Physiology · doi:10.1146/annurev-physiol-042022-025619 · Cited by 77
Angel‐Morales, G., Noratto, G. D., & Mertens‐Talcott, S. U. (2012) · Food & Function · doi:10.1039/c2fo10271d · Cited by 71
Arciszewski, M. B., Sand, E., & Ekblad, E. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2007.09.021 · Cited by 68
Stromal Cells in the Pathogenesis of Inflammatory Bowel Disease
Barnhoorn, M. C., Hakuno, S. K., Bruckner, R. S., Rogler, G., Hawinkels, L. J. A. C., & Scharl, M. M. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa009 · Cited by 67
Inflammatory bowel disease: Moving toward a stem cell-based therapy
Lanzoni, G., Roda, G., Belluzzi, A., Roda, E., & Bagnara, G. P. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4616 · Cited by 65
Activation of smooth muscle and myenteric plexus cells of jejunum via toll‐like receptor 4
Rumio, C., Besusso, D., Arnaboldi, F., Palazzo, M., Selleri, S., Gariboldi, S., Akira, S., Uematsu, S., Bignami, P., Ceriani, V., et al. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20632 · Cited by 63
Dohi, T., & Burkly, L. C. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0112042 · Cited by 62
Bettenworth, D., & Rieder, F. (2017) · Digestive Diseases · doi:10.1159/000449079 · Cited by 62
Zhao, S., Dejanovic, D., Yao, P., Bhilocha, S., Sadler, T., Schirbel, A., West, G., Doyon, G., Lopez, R., Mao, R., et al. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0259-9 · Cited by 59
Horiguchi, H., Endo, M., Kawane, K., Kadomatsu, T., Terada, K., Morinaga, J., Araki, K., Miyata, K., & Oike, Y. (2017) · The EMBO Journal · doi:10.15252/embj.201695690 · Cited by 61
Toll-like receptor signaling in parasitic infections
Ashour, D. S. (2015) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2015.1037286 · Cited by 62
Mechanisms of Tissue Remodeling in Inflammatory Bowel Disease
Rieder, F., & Fiocchi, C. (2013) · Digestive Diseases · doi:10.1159/000353364 · Cited by 59
Scaldaferri, F., Sans, M., Vetrano, S., Correale, C., Arena, V., Pagano, N., Rando, G., Romeo, F., Potenza, A. E., Repici, A., et al. (2009) · European Journal of Immunology · doi:10.1002/eji.200838316 · Cited by 57
Immunological Regulation of Intestinal Fibrosis in Inflammatory Bowel Disease
Bamias, G., Pizarro, T. T., & Cominelli, F. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab251 · Cited by 57
Intestinal fibrosis in inflammatory bowel disease: progress in basic and clinical science
Rieder, F., & Fiocchi, C. (2008) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3282ff8b36 · Cited by 55
Stromal and immune cells in gut fibrosis: the myofibroblast and the scarface
Valatas, V. (2017) · Annals of Gastroenterology · doi:10.20524/aog.2017.0146 · Cited by 55
Ellermann, M., Gharaibeh, R. Z., Fulbright, L. E., Dogan, B., Moore, L. N., Broberg, C. A., Lopez, L. R., Rothemich, A., Herzog, J., Rogala, A. R., et al. (2019) · Infection and Immunity · doi:10.1128/iai.00587-19 · Cited by 54
Wang, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25442 · Cited by 53
TLRs and NODs mRNA expression pattern in healthy mouse eye
Rodríguez–Martínez, S. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2004.056218 · Cited by 53
BMP signaling in homeostasis, transformation and inflammatory response of intestinal epithelium
Wang, S., & Chen, Y. (2018) · Science China Life Sciences · doi:10.1007/s11427-018-9310-7 · Cited by 55
Bacterial lipopolysaccharide promotes profibrotic activation of intestinal fibroblasts
Burke, J. P., Cunningham, M. F., Watson, R. W. G., Docherty, N. G., Coffey, J. C., & O’Connell, P. R. (2010) · British journal of surgery · doi:10.1002/bjs.7045 · Cited by 51
Metadata
- Authors
- Otte, J.-M., Rosenberg, I. M., & Podolsky, D. K.
- Affiliations
- Harvard University (US)
- Corresponding author
- Podolsky, Daniel K
- ORCID
- Podolsky, Daniel K
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2003-06
- Volume
- 124
- Issue
- 7
- Pages
- 1866-1878
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1984107869
- Cited by
- 242
- References
- 63
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 7 · 2023: 5 · 2022: 6 · 2021: 9 · 2020: 11 · 2019: 10 · 2018: 15 · 2017: 7 · 2016: 6 · 2015: 17 · 2014: 12 · 2013: 11 · 2012: 16
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK 433-51, R01 DK 60049, R01DK060049, P30DK043351)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- intestinal myofibroblasts, innate immunity, Toll-like receptors, NOD1, NOD2, lipopolysaccharide, lipoteichoic acid, MyD88, TIRAP, MAPK signaling, p65 nuclear translocation, interleukin-8, colonic myofibroblasts, lung myofibroblasts, bacterial sensing
- MeSH terms
- Cells, Cultured, Colon, Fibroblasts, Humans, Immunity, Innate, Intestinal Mucosa, Lipopolysaccharides, Membrane Glycoproteins, Receptors, Cell Surface, RNA, Messenger, Teichoic Acids, Inflammatory Bowel Diseases, Interleukin-8, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Mitogen-Activated Protein Kinases, Toll-Like Receptors, Toll-Like Receptor 1, Toll-Like Receptor 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review